Evidence map›Paper›PMID 33658796›Full record

ArticleOncoTargets and therapy2021

Anti-Proliferative, Pro-Apoptotic, Anti-Migrative and Tumor-Inhibitory Effects and Pleiotropic Mechanism of Theaflavin on B16F10 Melanoma Cells.

Lei Zhang, Shijie Meng, Bo Yan, Jie Chen, Li Zhou, Letian Shan, Ying Wang

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Medicinal Value ofInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lei Zhang *School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou, People's Republic of China.
Shijie Meng *The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Bo Yan *The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Jie ChenThe First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Li ZhouThe First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.ORCID 0000-0003-1083-0211
Letian ShanThe First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.ORCID 0000-0003-4926-0527
Ying WangSchool of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Zhejiang Chinese Medical University · CNZhejiang University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTheaflavin (TF) is a primary pigment of tea, exhibiting anti-proliferative, pro-apoptotic and anti-metastatic activities on cancer cell lines. However, it is unknown whether TF is effective in treating melanoma cells.

methodsTo determine the effects of TF on melanoma cells, we conducted in vitro assays of cell viability, DAPI staining, wound healing, transwell, and flow cytometry as well as in vivo experiments on B16F10-bearing mouse model. Real-time PCR (qPCR) and Western blot (WB) were conducted to explore the molecular actions of TF.

resultsThe cell viability assay showed that TF exerted inhibitory effect on B16F10 cells in a dose-dependent manner from 40 to 400 μg/mL, with IC

conclusionIt can be concluded that TB exhibited anti-proliferative, pro-apoptotic, anti-migrative, and tumor-inhibitory effects on melanoma cells through pleiotropic actions on the above pathways. This study provides new evidence of anti-melanoma efficacy and mechanism of TF, contributing to the development of TF-derived natural products for melanoma therapy.

Indexed as

apoptosisB16F10JNKmelanomap53theaflavin

Identifiers

PMID33658796
PMCPMC7920628
OpenAlexW3132457317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.